Agreement and diagnostic performance of a smartphone-based bilirubin assessment tool for screening neonatal hyperbilirubinemia - Takeaways - MDSpire

Agreement and diagnostic performance of a smartphone-based bilirubin assessment tool for screening neonatal hyperbilirubinemia

  • By

  • Ya Zhao

  • Anlan Xu

  • Tonghui Suo

  • Fengqin Zhang

  • Mingwu Chen

  • June 19, 2026

  • 0 min

Share

  • 1

    Neonatal hyperbilirubinemia can lead to severe neurological injury if not detected and treated promptly.

  • 2

    A smartphone application for bilirubin measurement was evaluated against total serum bilirubin (TSB) and transcutaneous bilirubin (TcB) methods.

  • 3

    The study included 121 neonates, with mobile app-derived bilirubin showing a mean difference of −2.42 μmol/L compared to TSB.

  • 4

    Mobile app-derived bilirubin demonstrated good diagnostic performance, with an area under the curve of 0.936, sensitivity of 0.912, and specificity of 0.908.

  • 5

    The smartphone-based approach has potential as a supplementary tool for neonatal hyperbilirubinemia screening, pending further validation.

Original Source(s)

Agreement and diagnostic performance of a smartphone-based bilirubin assessment tool for screening neonatal hyperbilirubinemia

  • by Ya Zhao, Anlan Xu, Tonghui Suo, Fengqin Zhang, Mingwu Chen

  • June 19, 2026

Related Content

Case Report: a novel non-canonical splice site variant in COL4A5 in a patient with Alport syndrome

Medical Oddities: Gummies Good for the Gums

From gummies to hookworms, trackers to vibrating pills, medicine took some unexpected turns this week.

Multi-modal deep learning model for bipolar depression adolescents with verbal auditory hallucinations